Please Wait

Applying Filters...

Sulisobenzone
USDMF
Table View

DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Data Compilation
#PharmaFlow

Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

Stock Recap
#PipelineProspector

Sulisobenzone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF, 3 NDC API

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 4 DKSH, 1 Pharm-RX Chemical, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Kerry, 1 Pluviaendo, 3 Shandong Focus Biotechnology Co., Ltd, 1 Sigachi Industries, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

9 Topical, 4 Emulsifying Agents, 4 Thickeners and Stabilizers, 4 Parenteral, 3 Chewable & Orodispersible Aids, 3 Coating Systems & Additives, 3 Fillers, Diluents & Binders, 3 Taste Masking, 3 Surfactant & Foaming Agents, 3 Controlled & Modified Release, 2 Lubricants & Glidants, 2 Disintegrants & Superdisintegrants, 2 API Stability Enhancers, 2 Direct Compression, 2 Rheology Modifiers, 1 Co-Processed Excipients, 1 Film Formers & Plasticizers, 1 Solubilizers